Advertisement

Index by Author

May 1998; 47 (5)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Adams-Huet, B

    • Obesity-independent hyperinsulinemia in nondiabetic first-degree relatives of individuals with type 2 diabetes. Diabetes May 1998 47:788-792; doi:10.2337/diabetes.47.5.788

  2. Asada, N

    • Identification of alpha- and beta-cells in intact isolated islets of Langerhans by their characteristic cytoplasmic Ca2+ concentration dynamics and immunocytochemical staining. Diabetes May 1998 47:751-757; doi:10.2337/diabetes.47.5.751

  3. Auwerx, J

    • Overexpression of placental leptin in diabetic pregnancy: a critical role for insulin. Diabetes May 1998 47:847-850; doi:10.2337/diabetes.47.5.847

B

  1. Barber, A J

    • Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes May 1998 47:815-820; doi:10.2337/diabetes.47.5.815

  2. Bar-Tana, J

    • Development of insulin resistance in the JCR:LA-cp rat: role of triacylglycerols and effects of MEDICA 16. Diabetes May 1998 47:770-778; doi:10.2337/diabetes.47.5.770

  3. Basdevant, A

    • Mutation screening of the human UCP 2 gene in normoglycemic and NIDDM morbidly obese patients: lack of association between new UCP 2 polymorphisms and obesity in French Caucasians. Diabetes May 1998 47:840-842; doi:10.2337/diabetes.47.5.840

  4. Bedford, D

    • Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects. Diabetes May 1998 47:779-787; doi:10.2337/diabetes.47.5.779

  5. Bell, G I

    • Mutations in the coding region of the insulin promoter factor 1 gene are not a common cause of maturity-onset diabetes of the young in Japanese subjects. Diabetes May 1998 47:845-846; doi:10.2337/diabetes.47.5.845

  6. Bennett, P H

    • Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes May 1998 47:821-830; doi:10.2337/diabetes.47.5.821

  7. Bergman, R N

    • Role of portal insulin delivery in the disappearance of intravenous glucose and assessment of insulin sensitivity. Diabetes May 1998 47:714-720; doi:10.2337/diabetes.47.5.714

  8. Buckingham, R E

    • Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro. Diabetes May 1998 47:810-814; doi:10.2337/diabetes.47.5.810

  9. Busch, K

    • An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) gene. Diabetes May 1998 47:851-854; doi:10.2337/diabetes.47.5.851

  10. Butler, P C

    • Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide. Diabetes May 1998 47:743-750; doi:10.2337/diabetes.47.5.743

C

  1. Carty, M D

    • Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide. Diabetes May 1998 47:743-750; doi:10.2337/diabetes.47.5.743

  2. Caslake, M

    • Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects. Diabetes May 1998 47:779-787; doi:10.2337/diabetes.47.5.779

  3. Catherwood, M A

    • Glucose-induced oxidative stress in vascular contractile cells: comparison of aortic smooth muscle cells and retinal pericytes. Diabetes May 1998 47:801-809; doi:10.2337/diabetes.47.5.801

  4. Cauzac, M

    • Overexpression of placental leptin in diabetic pregnancy: a critical role for insulin. Diabetes May 1998 47:847-850; doi:10.2337/diabetes.47.5.847

  5. Chattington, P D

    • Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro. Diabetes May 1998 47:810-814; doi:10.2337/diabetes.47.5.810

  6. Chen, M M

    • Short-term exposure to tumor necrosis factor-alpha does not affect insulin-stimulated glucose uptake in skeletal muscle. Diabetes May 1998 47:721-726; doi:10.2337/diabetes.47.5.721

  7. Chèvre, J C

    • Insulin promoter factor 1 gene is not a major cause of maturity-onset diabetes of the young in French Caucasians. Diabetes May 1998 47:843-844; doi:10.2337/diabetes.47.5.843

  8. Chisholm, D

    • The metabolically obese, normal-weight individual revisited. Diabetes May 1998 47:699-713; doi:10.2337/diabetes.47.5.699

  9. Clement, K

    • Mutation screening of the human UCP 2 gene in normoglycemic and NIDDM morbidly obese patients: lack of association between new UCP 2 polymorphisms and obesity in French Caucasians. Diabetes May 1998 47:840-842; doi:10.2337/diabetes.47.5.840

  10. Colle, E

    • A functional analysis of the role of IGF2 in IDDM2-encoded susceptibility to type 1 diabetes. Diabetes May 1998 47:831-836; doi:10.2337/diabetes.47.5.831

D

  1. Deacon, C F

    • Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig. Diabetes May 1998 47:764-769; doi:10.2337/diabetes.47.5.764

  2. Dice, C

    • Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes May 1998 47:815-820; doi:10.2337/diabetes.47.5.815

  3. Dolphin, P J

    • Development of insulin resistance in the JCR:LA-cp rat: role of triacylglycerols and effects of MEDICA 16. Diabetes May 1998 47:770-778; doi:10.2337/diabetes.47.5.770

  4. Doria, A

    • An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) gene. Diabetes May 1998 47:851-854; doi:10.2337/diabetes.47.5.851

  5. Dunne, M J

    • Glucose activates both K(ATP) channel-dependent and K(ATP) channel-independent signaling pathways in human islets. Diabetes May 1998 47:758-763; doi:10.2337/diabetes.47.5.758

E

  1. Eisenbarth, G S

    • Definition of multiple ICA512/phogrin autoantibody epitopes and detection of intramolecular epitope spreading in relatives of patients with type 1 diabetes. Diabetes May 1998 47:733-742; doi:10.2337/diabetes.47.5.733

  2. Epplen, C

    • An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) gene. Diabetes May 1998 47:851-854; doi:10.2337/diabetes.47.5.851

F

  1. Froguel, P

    • Mutation screening of the human UCP 2 gene in normoglycemic and NIDDM morbidly obese patients: lack of association between new UCP 2 polymorphisms and obesity in French Caucasians. Diabetes May 1998 47:840-842; doi:10.2337/diabetes.47.5.840
    • Insulin promoter factor 1 gene is not a major cause of maturity-onset diabetes of the young in French Caucasians. Diabetes May 1998 47:843-844; doi:10.2337/diabetes.47.5.843

G

  1. Gabriel, M

    • Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes May 1998 47:793-800; doi:10.2337/diabetes.47.5.793

  2. Giannakidou, E

    • An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) gene. Diabetes May 1998 47:851-854; doi:10.2337/diabetes.47.5.851

  3. Girard, J

    • Overexpression of placental leptin in diabetic pregnancy: a critical role for insulin. Diabetes May 1998 47:847-850; doi:10.2337/diabetes.47.5.847

  4. Goodyer, C G

    • A functional analysis of the role of IGF2 in IDDM2-encoded susceptibility to type 1 diabetes. Diabetes May 1998 47:831-836; doi:10.2337/diabetes.47.5.831

  5. Grabs, R

    • A functional analysis of the role of IGF2 in IDDM2-encoded susceptibility to type 1 diabetes. Diabetes May 1998 47:831-836; doi:10.2337/diabetes.47.5.831

  6. Graham, S E

    • Development of insulin resistance in the JCR:LA-cp rat: role of triacylglycerols and effects of MEDICA 16. Diabetes May 1998 47:770-778; doi:10.2337/diabetes.47.5.770

  7. Gulve, E A

    • Short-term exposure to tumor necrosis factor-alpha does not affect insulin-stimulated glucose uptake in skeletal muscle. Diabetes May 1998 47:721-726; doi:10.2337/diabetes.47.5.721

  8. Guy-Grand, B

    • Mutation screening of the human UCP 2 gene in normoglycemic and NIDDM morbidly obese patients: lack of association between new UCP 2 polymorphisms and obesity in French Caucasians. Diabetes May 1998 47:840-842; doi:10.2337/diabetes.47.5.840

H

  1. Habener, J F

    • Insulin promoter factor 1 gene is not a major cause of maturity-onset diabetes of the young in French Caucasians. Diabetes May 1998 47:843-844; doi:10.2337/diabetes.47.5.843

  2. Haffner, S M

    • Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes May 1998 47:793-800; doi:10.2337/diabetes.47.5.793

  3. Hani, E H

    • Insulin promoter factor 1 gene is not a major cause of maturity-onset diabetes of the young in French Caucasians. Diabetes May 1998 47:843-844; doi:10.2337/diabetes.47.5.843

  4. Hansen, P A

    • Short-term exposure to tumor necrosis factor-alpha does not affect insulin-stimulated glucose uptake in skeletal muscle. Diabetes May 1998 47:721-726; doi:10.2337/diabetes.47.5.721

  5. Hanson, R L

    • Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes May 1998 47:821-830; doi:10.2337/diabetes.47.5.821

  6. Hara, M

    • Mutations in the coding region of the insulin promoter factor 1 gene are not a common cause of maturity-onset diabetes of the young in Japanese subjects. Diabetes May 1998 47:845-846; doi:10.2337/diabetes.47.5.845

  7. Hart, S E

    • Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide. Diabetes May 1998 47:743-750; doi:10.2337/diabetes.47.5.743

  8. Hauguel-de Mouzon, S

    • Overexpression of placental leptin in diabetic pregnancy: a critical role for insulin. Diabetes May 1998 47:847-850; doi:10.2337/diabetes.47.5.847

  9. Hayward, A

    • Molecular scanning of the insulin receptor substrate 1 gene in subjects with severe insulin resistance: detection and functional analysis of a naturally occurring mutation in a YMXM motif. Diabetes May 1998 47:837-839; doi:10.2337/diabetes.47.5.837

  10. Hebinck, J

    • An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) gene. Diabetes May 1998 47:851-854; doi:10.2337/diabetes.47.5.851

  11. Holloszy, J O

    • Short-term exposure to tumor necrosis factor-alpha does not affect insulin-stimulated glucose uptake in skeletal muscle. Diabetes May 1998 47:721-726; doi:10.2337/diabetes.47.5.721

  12. Holst, J J

    • Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig. Diabetes May 1998 47:764-769; doi:10.2337/diabetes.47.5.764

  13. Hughes, T E

    • Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig. Diabetes May 1998 47:764-769; doi:10.2337/diabetes.47.5.764

  14. Humphreys, P

    • Molecular scanning of the insulin receptor substrate 1 gene in subjects with severe insulin resistance: detection and functional analysis of a naturally occurring mutation in a YMXM motif. Diabetes May 1998 47:837-839; doi:10.2337/diabetes.47.5.837

  15. Hutton, J C

    • Definition of multiple ICA512/phogrin autoantibody epitopes and detection of intramolecular epitope spreading in relatives of patients with type 1 diabetes. Diabetes May 1998 47:733-742; doi:10.2337/diabetes.47.5.733

I

  1. Imperatore, G

    • Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes May 1998 47:821-830; doi:10.2337/diabetes.47.5.821

  2. Ishikawa, M

    • Obesity-independent hyperinsulinemia in nondiabetic first-degree relatives of individuals with type 2 diabetes. Diabetes May 1998 47:788-792; doi:10.2337/diabetes.47.5.788

  3. Iwamoto, Y

    • Mutations in the coding region of the insulin promoter factor 1 gene are not a common cause of maturity-onset diabetes of the young in Japanese subjects. Diabetes May 1998 47:845-846; doi:10.2337/diabetes.47.5.845

  4. Iwanaga, T

    • Identification of alpha- and beta-cells in intact isolated islets of Langerhans by their characteristic cytoplasmic Ca2+ concentration dynamics and immunocytochemical staining. Diabetes May 1998 47:751-757; doi:10.2337/diabetes.47.5.751

  5. Iwasaki, N

    • Mutations in the coding region of the insulin promoter factor 1 gene are not a common cause of maturity-onset diabetes of the young in Japanese subjects. Diabetes May 1998 47:845-846; doi:10.2337/diabetes.47.5.845

J

  1. Jackson, R

    • Molecular scanning of the insulin receptor substrate 1 gene in subjects with severe insulin resistance: detection and functional analysis of a naturally occurring mutation in a YMXM motif. Diabetes May 1998 47:837-839; doi:10.2337/diabetes.47.5.837

  2. James, R F

    • Human islets of Langerhans express Fas ligand and undergo apoptosis in response to interleukin-1beta and Fas ligation. Diabetes May 1998 47:727-732; doi:10.2337/diabetes.47.5.727
    • Glucose activates both K(ATP) channel-dependent and K(ATP) channel-independent signaling pathways in human islets. Diabetes May 1998 47:758-763; doi:10.2337/diabetes.47.5.758

  3. Janson, J

    • Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide. Diabetes May 1998 47:743-750; doi:10.2337/diabetes.47.5.743

K

  1. Kahn, C R

    • An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) gene. Diabetes May 1998 47:851-854; doi:10.2337/diabetes.47.5.851

  2. Kanno, T

    • Identification of alpha- and beta-cells in intact isolated islets of Langerhans by their characteristic cytoplasmic Ca2+ concentration dynamics and immunocytochemical staining. Diabetes May 1998 47:751-757; doi:10.2337/diabetes.47.5.751

  3. Kawasaki, E

    • Definition of multiple ICA512/phogrin autoantibody epitopes and detection of intramolecular epitope spreading in relatives of patients with type 1 diabetes. Diabetes May 1998 47:733-742; doi:10.2337/diabetes.47.5.733

  4. Knebel, B

    • An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) gene. Diabetes May 1998 47:851-854; doi:10.2337/diabetes.47.5.851

  5. Knowler, W C

    • Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes May 1998 47:821-830; doi:10.2337/diabetes.47.5.821

  6. Kobes, S

    • Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes May 1998 47:821-830; doi:10.2337/diabetes.47.5.821

  7. Kotzka, J

    • An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) gene. Diabetes May 1998 47:851-854; doi:10.2337/diabetes.47.5.851

  8. Kreutter, D K

    • Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide. Diabetes May 1998 47:743-750; doi:10.2337/diabetes.47.5.743

  9. Krone, W

    • An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) gene. Diabetes May 1998 47:851-854; doi:10.2337/diabetes.47.5.851

  10. Krook, A

    • Molecular scanning of the insulin receptor substrate 1 gene in subjects with severe insulin resistance: detection and functional analysis of a naturally occurring mutation in a YMXM motif. Diabetes May 1998 47:837-839; doi:10.2337/diabetes.47.5.837

L

  1. Lahlou, N

    • Overexpression of placental leptin in diabetic pregnancy: a critical role for insulin. Diabetes May 1998 47:847-850; doi:10.2337/diabetes.47.5.847

  2. Lau, D C

    • Development of insulin resistance in the JCR:LA-cp rat: role of triacylglycerols and effects of MEDICA 16. Diabetes May 1998 47:770-778; doi:10.2337/diabetes.47.5.770

  3. Lepercq, J

    • Overexpression of placental leptin in diabetic pregnancy: a critical role for insulin. Diabetes May 1998 47:847-850; doi:10.2337/diabetes.47.5.847

  4. Lewis, H

    • Molecular scanning of the insulin receptor substrate 1 gene in subjects with severe insulin resistance: detection and functional analysis of a naturally occurring mutation in a YMXM motif. Diabetes May 1998 47:837-839; doi:10.2337/diabetes.47.5.837

  5. Lieth, E

    • Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes May 1998 47:815-820; doi:10.2337/diabetes.47.5.815

  6. Lindner, T H

    • Mutations in the coding region of the insulin promoter factor 1 gene are not a common cause of maturity-onset diabetes of the young in Japanese subjects. Diabetes May 1998 47:845-846; doi:10.2337/diabetes.47.5.845

  7. Liu, W H

    • Glucose-induced oxidative stress in vascular contractile cells: comparison of aortic smooth muscle cells and retinal pericytes. Diabetes May 1998 47:801-809; doi:10.2337/diabetes.47.5.801

  8. Loweth, A C

    • Human islets of Langerhans express Fas ligand and undergo apoptosis in response to interleukin-1beta and Fas ligation. Diabetes May 1998 47:727-732; doi:10.2337/diabetes.47.5.727

M

  1. Malmström, R

    • Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects. Diabetes May 1998 47:779-787; doi:10.2337/diabetes.47.5.779

  2. McGinty, A M

    • Glucose-induced oxidative stress in vascular contractile cells: comparison of aortic smooth muscle cells and retinal pericytes. Diabetes May 1998 47:801-809; doi:10.2337/diabetes.47.5.801

  3. McMaster, D

    • Glucose-induced oxidative stress in vascular contractile cells: comparison of aortic smooth muscle cells and retinal pericytes. Diabetes May 1998 47:801-809; doi:10.2337/diabetes.47.5.801

  4. Mittelman, S D

    • Role of portal insulin delivery in the disappearance of intravenous glucose and assessment of insulin sensitivity. Diabetes May 1998 47:714-720; doi:10.2337/diabetes.47.5.714

  5. Morgan, N G

    • Human islets of Langerhans express Fas ligand and undergo apoptosis in response to interleukin-1beta and Fas ligation. Diabetes May 1998 47:727-732; doi:10.2337/diabetes.47.5.727

  6. Mueller-Berghaus, J

    • An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) gene. Diabetes May 1998 47:851-854; doi:10.2337/diabetes.47.5.851

  7. Mueller-Wieland, D

    • An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) gene. Diabetes May 1998 47:851-854; doi:10.2337/diabetes.47.5.851

  8. Mykkänen, L

    • Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes May 1998 47:793-800; doi:10.2337/diabetes.47.5.793

N

  1. Naderali, E K

    • Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro. Diabetes May 1998 47:810-814; doi:10.2337/diabetes.47.5.810

  2. Neverova, M

    • Mutation screening of the human UCP 2 gene in normoglycemic and NIDDM morbidly obese patients: lack of association between new UCP 2 polymorphisms and obesity in French Caucasians. Diabetes May 1998 47:840-842; doi:10.2337/diabetes.47.5.840

  3. Niwa, K

    • Identification of alpha- and beta-cells in intact isolated islets of Langerhans by their characteristic cytoplasmic Ca2+ concentration dynamics and immunocytochemical staining. Diabetes May 1998 47:751-757; doi:10.2337/diabetes.47.5.751

  4. Nolte, L A

    • Short-term exposure to tumor necrosis factor-alpha does not affect insulin-stimulated glucose uptake in skeletal muscle. Diabetes May 1998 47:721-726; doi:10.2337/diabetes.47.5.721

O

  1. O'Rahilly, S

    • Molecular scanning of the insulin receptor substrate 1 gene in subjects with severe insulin resistance: detection and functional analysis of a naturally occurring mutation in a YMXM motif. Diabetes May 1998 47:837-839; doi:10.2337/diabetes.47.5.837

  2. Ogata, M

    • Mutations in the coding region of the insulin promoter factor 1 gene are not a common cause of maturity-onset diabetes of the young in Japanese subjects. Diabetes May 1998 47:845-846; doi:10.2337/diabetes.47.5.845

  3. Otabe, S

    • Mutation screening of the human UCP 2 gene in normoglycemic and NIDDM morbidly obese patients: lack of association between new UCP 2 polymorphisms and obesity in French Caucasians. Diabetes May 1998 47:840-842; doi:10.2337/diabetes.47.5.840

P

  1. Packard, C J

    • Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects. Diabetes May 1998 47:779-787; doi:10.2337/diabetes.47.5.779

  2. Parker, J C

    • Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide. Diabetes May 1998 47:743-750; doi:10.2337/diabetes.47.5.743

  3. Paz, V P

    • Mutations in the coding region of the insulin promoter factor 1 gene are not a common cause of maturity-onset diabetes of the young in Japanese subjects. Diabetes May 1998 47:845-846; doi:10.2337/diabetes.47.5.845

  4. Pecqueur, C

    • Mutation screening of the human UCP 2 gene in normoglycemic and NIDDM morbidly obese patients: lack of association between new UCP 2 polymorphisms and obesity in French Caucasians. Diabetes May 1998 47:840-842; doi:10.2337/diabetes.47.5.840

  5. Pettitt, D J

    • Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes May 1998 47:821-830; doi:10.2337/diabetes.47.5.821

  6. Pfeiffer, A

    • An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) gene. Diabetes May 1998 47:851-854; doi:10.2337/diabetes.47.5.851

  7. Pi-Sunyer, X

    • The metabolically obese, normal-weight individual revisited. Diabetes May 1998 47:699-713; doi:10.2337/diabetes.47.5.699

  8. Polychronakos, C

    • A functional analysis of the role of IGF2 in IDDM2-encoded susceptibility to type 1 diabetes. Diabetes May 1998 47:831-836; doi:10.2337/diabetes.47.5.831

  9. Pruneda, M L

    • Obesity-independent hyperinsulinemia in nondiabetic first-degree relatives of individuals with type 2 diabetes. Diabetes May 1998 47:788-792; doi:10.2337/diabetes.47.5.788

R

  1. Raimbault, S

    • Mutation screening of the human UCP 2 gene in normoglycemic and NIDDM morbidly obese patients: lack of association between new UCP 2 polymorphisms and obesity in French Caucasians. Diabetes May 1998 47:840-842; doi:10.2337/diabetes.47.5.840

  2. Raskin, P

    • Obesity-independent hyperinsulinemia in nondiabetic first-degree relatives of individuals with type 2 diabetes. Diabetes May 1998 47:788-792; doi:10.2337/diabetes.47.5.788

  3. Ratz, M J

    • Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes May 1998 47:815-820; doi:10.2337/diabetes.47.5.815

  4. Rebrin, K

    • Role of portal insulin delivery in the disappearance of intravenous glucose and assessment of insulin sensitivity. Diabetes May 1998 47:714-720; doi:10.2337/diabetes.47.5.714

  5. Rewers, M J

    • Definition of multiple ICA512/phogrin autoantibody epitopes and detection of intramolecular epitope spreading in relatives of patients with type 1 diabetes. Diabetes May 1998 47:733-742; doi:10.2337/diabetes.47.5.733

  6. Richardson, M

    • Development of insulin resistance in the JCR:LA-cp rat: role of triacylglycerols and effects of MEDICA 16. Diabetes May 1998 47:770-778; doi:10.2337/diabetes.47.5.770

  7. Rich, N

    • Mutation screening of the human UCP 2 gene in normoglycemic and NIDDM morbidly obese patients: lack of association between new UCP 2 polymorphisms and obesity in French Caucasians. Diabetes May 1998 47:840-842; doi:10.2337/diabetes.47.5.840

  8. Ricquier, D

    • Mutation screening of the human UCP 2 gene in normoglycemic and NIDDM morbidly obese patients: lack of association between new UCP 2 polymorphisms and obesity in French Caucasians. Diabetes May 1998 47:840-842; doi:10.2337/diabetes.47.5.840

  9. Ristow, M

    • An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) gene. Diabetes May 1998 47:851-854; doi:10.2337/diabetes.47.5.851

  10. Robbins, D C

    • Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes May 1998 47:793-800; doi:10.2337/diabetes.47.5.793

  11. Ruderman, N

    • The metabolically obese, normal-weight individual revisited. Diabetes May 1998 47:699-713; doi:10.2337/diabetes.47.5.699

  12. Russell, J C

    • Development of insulin resistance in the JCR:LA-cp rat: role of triacylglycerols and effects of MEDICA 16. Diabetes May 1998 47:770-778; doi:10.2337/diabetes.47.5.770

S

  1. Scarpello, J H

    • Human islets of Langerhans express Fas ligand and undergo apoptosis in response to interleukin-1beta and Fas ligation. Diabetes May 1998 47:727-732; doi:10.2337/diabetes.47.5.727

  2. Schluter, J M

    • Short-term exposure to tumor necrosis factor-alpha does not affect insulin-stimulated glucose uptake in skeletal muscle. Diabetes May 1998 47:721-726; doi:10.2337/diabetes.47.5.721

  3. Schneider, S

    • The metabolically obese, normal-weight individual revisited. Diabetes May 1998 47:699-713; doi:10.2337/diabetes.47.5.699

  4. Sharpe, P C

    • Glucose-induced oxidative stress in vascular contractile cells: comparison of aortic smooth muscle cells and retinal pericytes. Diabetes May 1998 47:801-809; doi:10.2337/diabetes.47.5.801

  5. Sharp, G W

    • Glucose activates both K(ATP) channel-dependent and K(ATP) channel-independent signaling pathways in human islets. Diabetes May 1998 47:758-763; doi:10.2337/diabetes.47.5.758

  6. Shepherd, J

    • Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects. Diabetes May 1998 47:779-787; doi:10.2337/diabetes.47.5.779

  7. Shibuya, I

    • Identification of alpha- and beta-cells in intact isolated islets of Langerhans by their characteristic cytoplasmic Ca2+ concentration dynamics and immunocytochemical staining. Diabetes May 1998 47:751-757; doi:10.2337/diabetes.47.5.751

  8. Shillabeer, G

    • Development of insulin resistance in the JCR:LA-cp rat: role of triacylglycerols and effects of MEDICA 16. Diabetes May 1998 47:770-778; doi:10.2337/diabetes.47.5.770

  9. Siddle, K

    • Molecular scanning of the insulin receptor substrate 1 gene in subjects with severe insulin resistance: detection and functional analysis of a naturally occurring mutation in a YMXM motif. Diabetes May 1998 47:837-839; doi:10.2337/diabetes.47.5.837

  10. Soeller, W C

    • Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide. Diabetes May 1998 47:743-750; doi:10.2337/diabetes.47.5.743

  11. Steil, G M

    • Role of portal insulin delivery in the disappearance of intravenous glucose and assessment of insulin sensitivity. Diabetes May 1998 47:714-720; doi:10.2337/diabetes.47.5.714

  12. Stevenson, R W

    • Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide. Diabetes May 1998 47:743-750; doi:10.2337/diabetes.47.5.743

  13. Stewart, P

    • Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects. Diabetes May 1998 47:779-787; doi:10.2337/diabetes.47.5.779

  14. Stoffers, D A

    • Insulin promoter factor 1 gene is not a major cause of maturity-onset diabetes of the young in French Caucasians. Diabetes May 1998 47:843-844; doi:10.2337/diabetes.47.5.843

  15. Straub, S G

    • Glucose activates both K(ATP) channel-dependent and K(ATP) channel-independent signaling pathways in human islets. Diabetes May 1998 47:758-763; doi:10.2337/diabetes.47.5.758

  16. Strother, J M

    • Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes May 1998 47:815-820; doi:10.2337/diabetes.47.5.815

T

  1. Tanase, D

    • Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes May 1998 47:815-820; doi:10.2337/diabetes.47.5.815

  2. Taskinen, M R

    • Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects. Diabetes May 1998 47:779-787; doi:10.2337/diabetes.47.5.779

  3. Timsit, J

    • Overexpression of placental leptin in diabetic pregnancy: a critical role for insulin. Diabetes May 1998 47:847-850; doi:10.2337/diabetes.47.5.847

  4. Trimble, E R

    • Glucose-induced oxidative stress in vascular contractile cells: comparison of aortic smooth muscle cells and retinal pericytes. Diabetes May 1998 47:801-809; doi:10.2337/diabetes.47.5.801

V

  1. Vafiadis, P

    • A functional analysis of the role of IGF2 in IDDM2-encoded susceptibility to type 1 diabetes. Diabetes May 1998 47:831-836; doi:10.2337/diabetes.47.5.831

  2. Vasseur, F

    • Mutation screening of the human UCP 2 gene in normoglycemic and NIDDM morbidly obese patients: lack of association between new UCP 2 polymorphisms and obesity in French Caucasians. Diabetes May 1998 47:840-842; doi:10.2337/diabetes.47.5.840

  3. Vorgerd, M

    • An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) gene. Diabetes May 1998 47:851-854; doi:10.2337/diabetes.47.5.851

W

  1. Wagenknecht, L E

    • Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes May 1998 47:793-800; doi:10.2337/diabetes.47.5.793

  2. Walker, A B

    • Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro. Diabetes May 1998 47:810-814; doi:10.2337/diabetes.47.5.810

  3. Wang, X

    • Mutations in the coding region of the insulin promoter factor 1 gene are not a common cause of maturity-onset diabetes of the young in Japanese subjects. Diabetes May 1998 47:845-846; doi:10.2337/diabetes.47.5.845

  4. Warden, C

    • Mutation screening of the human UCP 2 gene in normoglycemic and NIDDM morbidly obese patients: lack of association between new UCP 2 polymorphisms and obesity in French Caucasians. Diabetes May 1998 47:840-842; doi:10.2337/diabetes.47.5.840

  5. Wenzel, L M

    • Development of insulin resistance in the JCR:LA-cp rat: role of triacylglycerols and effects of MEDICA 16. Diabetes May 1998 47:770-778; doi:10.2337/diabetes.47.5.770

  6. Whitehead, J P

    • Molecular scanning of the insulin receptor substrate 1 gene in subjects with severe insulin resistance: detection and functional analysis of a naturally occurring mutation in a YMXM motif. Diabetes May 1998 47:837-839; doi:10.2337/diabetes.47.5.837

  7. Williams, G

    • Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro. Diabetes May 1998 47:810-814; doi:10.2337/diabetes.47.5.810

  8. Williams, G T

    • Human islets of Langerhans express Fas ligand and undergo apoptosis in response to interleukin-1beta and Fas ligation. Diabetes May 1998 47:727-732; doi:10.2337/diabetes.47.5.727

X

  1. Xu, B

    • Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes May 1998 47:815-820; doi:10.2337/diabetes.47.5.815

Y

  1. Yki-Järvinen, H

    • Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects. Diabetes May 1998 47:779-787; doi:10.2337/diabetes.47.5.779

  2. Yue, K K

    • Glucose-induced oxidative stress in vascular contractile cells: comparison of aortic smooth muscle cells and retinal pericytes. Diabetes May 1998 47:801-809; doi:10.2337/diabetes.47.5.801

  3. Yu, L

    • Definition of multiple ICA512/phogrin autoantibody epitopes and detection of intramolecular epitope spreading in relatives of patients with type 1 diabetes. Diabetes May 1998 47:733-742; doi:10.2337/diabetes.47.5.733

Z

  1. Zaccaro, D J

    • Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes May 1998 47:793-800; doi:10.2337/diabetes.47.5.793

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement